Antidote to Bad Blood

Marty Cagan uses the Theranos collapse as a cautionary tale about founders who can sell a product concept but fail to discover and deliver a product that solves the real need. He argues that demand testing is the easy part and tells you little about a company's ability to build. He contrasts Theranos with Ventana, a medical device company that did the disciplined discovery and delivery work and changed medicine. He closes with three takeaways for product people: ethics in leaders matter, demand is easy to show, and product is hard. The piece is a short reminder that real product success depends on rigorous discovery and execution, not on convincing investors or buyers.

01Key takeaways

• Don't mistake proof of demand for proof that you can deliver a working product.
• Treat discovery as the hard work: confirm the real problem and whether your solution solves it.
• Leadership ethics matter, and a company's trustworthiness can collapse when they are absent.
• Regulated industries like health care still reward disciplined, empowered product discovery.
• Study both failures and successes in product origin stories to learn what separates them.

02Key sections

Origin stories and the Theranos cautionary tale

Cagan explains his interest in product origin stories and points to Theranos as an extreme, high-profile example of one that went badly wrong. He recommends the book Bad Blood for the full account.

Demand testing versus real product discovery

He argues that many founders can prove people want a concept, but that this is the easy part. The hard work is discovering and delivering a product that actually solves the problem.

Ventana as a counterexample

A friend pointed him to Ventana, a medical device company that tackled a hard problem through disciplined discovery and delivery. Its founder's book illustrates product discovery in a regulated industry by an empowered team.

Encouraging progress in health care

Cagan notes that other serious product companies, such as Grail and Suki, are making impressive progress in health care despite its challenges.

Three takeaways

He concludes with three lessons: leaders need ethics, demand validation says little about delivery ability, and building product is hard.

03From the post

“A partnership dedicated to teaching best practices to product teams and product leaders”

Summary and takeaways written by PM Atlas; quotes are short excerpts. © the original author.